Sorbus Biomedical is a Deep Tech company developing novel disruptive technology to improve the health and value of cells cultivated in the lab. We are looking for pre-seed of 500.000 Euro in Q3 2022 to revolutionize the field by launching a frugal technology which can be used in research, industry, and in healthcare. We intend to bring about a ISO-certified and CE-marked device for market launch in Scandinavia 2024.
Company’s Keywords:
<1
<
<